Comparison of WHO and RECIST Criteria for Response in Metastatic Colorectal Carcinoma
Jung-Hye Choi, Myung-Ju Ahn, Hyan-Chul Rhim, Jin-Woo Kim, Gang-Hong Lee, Young-Yeul Lee, In-Soon Kim
Cancer Res Treat. 2005;37(5):290-293.   Published online 2005 Oct 31     DOI:
Citations to this article as recorded by Crossref logo
A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics
Menghan Zhang, Qi Wang, Gongming Zhang, Guangming Li, Ronghua Jin, Huichun Xing
Frontiers in Pharmacology.2024;[Epub]     CrossRef
Immunotherapy Assessment: A New Paradigm for Radiologists
Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Igino Simonetti, Carmine Picone, Ester Simeone, Lucia Festino, Vito Vanella, Maria Grazia Vitale, Agnese Montanino, Alessandro Morabito, Francesco Izzo, Paolo Antonio Ascierto, Antonella Petrillo
Diagnostics.2023; 13(2): 302.     CrossRef
Study on the Application Value of Lung-RADS in the Differential Diagnosis of Benign and Malignant Lung Nodules
·马木提 依力夏提
Advances in Clinical Medicine.2023; 13(12): 20190.     CrossRef
Reliability and accuracy in radiographic measurements of musculoskeletal tumors
Alec S. Kellish, Sandra Miskiel, John Gaughan, Veniamin Barshay, Tae W. Kim, Christina J. Gutowski
Journal of Orthopaedic Research.2022; 40(7): 1654.     CrossRef
Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance
Anyue Yin, Johan G. C. van Hasselt, Henk-Jan Guchelaar, Lena E. Friberg, Dirk Jan A. R. Moes
Scientific Reports.2022;[Epub]     CrossRef
Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis
Christopher M. Black, Sam Keeping, Ali Mojebi, Karthik Ramakrishnan, Diana Chirovsky, Navneet Upadhyay, Dylan Maciel, Dieter Ayers
Frontiers in Oncology.2022;[Epub]     CrossRef
A quantitative and comparative evaluation of stereotactic spine radiosurgery local control: proposing a consistent measurement methodology
Ran Harel, Tehila Kaisman-Elbaz, Todd Emch, Paul Elson, Samuel T Chao, John H Suh, Lilyana Angelov
Neurosurgical Focus.2022; 53(5): E10.     CrossRef
Lung-RADS Version 1.1: Challenges and a Look Ahead, From the AJR Special Series on Radiology Reporting and Data Systems
Lydia Chelala, Rydhwana Hossain, Ella A. Kazerooni, Jared D. Christensen, Debra S. Dyer, Charles S. White
American Journal of Roentgenology.2021; 216(6): 1411.     CrossRef
Perillyl alcohol as a treatment for cancer: A systematic review
Aimée Obolari Durço, Lino Sérgio Rocha Conceição, Diego Santos de Souza, Carlos Anselmo Lima, Jullyana de Souza Siqueira Quintans, Márcio Roberto Viana dos Santos
Phytomedicine Plus.2021; 1(3): 100090.     CrossRef
Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review
Shah Naveed, Hasina Qari, Cao M Thau, Pipit Burasakarn, Abdul W Mir
Euroasian Journal of Hepato-Gastroenterology.2021; 11(2): 87.     CrossRef
Objective response rate assessment in oncology: Current situation and future expectations
Nuri Faruk Aykan, Tahsin Özatlı
World Journal of Clinical Oncology.2020; 11(2): 53.     CrossRef
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
Omar Abdel-Rahman, Zeinab Elsayed
Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
What scans we will read: imaging instrumentation trends in clinical oncology
Thomas Beyer, Luc Bidaut, John Dickson, Marc Kachelriess, Fabian Kiessling, Rainer Leitgeb, Jingfei Ma, Lalith Kumar Shiyam Sundar, Benjamin Theek, Osama Mawlawi
Cancer Imaging.2020;[Epub]     CrossRef
Herb–drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review
Chun Sing Lam, Lok Pui Cheng, Li Min Zhou, Yin Ting Cheung, Zhong Zuo
Chinese Medicine.2020;[Epub]     CrossRef
Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy
Sirisha L. Mushti, Flora Mulkey, Shenghui Tang, Harpreet Singh, Steven J. Lemery, Kirsten B. Goldberg, Rajeshwari Sridhara, Patricia Keegan, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret, Julia A. Beaver
Current Oncology Reports.2020;[Epub]     CrossRef
Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma
Yoko Tomita, Max Moldovan, Rachael Chang Lee, Amy HC Hsieh, Amanda Townsend, Timothy Price
Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer – A systematic review
Abdul R Hakeem, Michail Papoulas, Krishna V Menon
European Journal of Surgical Oncology.2019; 45(2): 83.     CrossRef
Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review
Inthuorn Kulma, Kanyarat Boonprasert, Kesara Na-Bangchang
Cancer Chemotherapy and Pharmacology.2019; 84(5): 959.     CrossRef
Identification of a 13‑gene‑based classifier as a potential biomarker to predict the effects of fluorouracil‑based chemotherapy in colorectal cancer
Zuhuan Gan, Qiyuan Zou, Yan Lin, Zihai Xu, Zhong Huang, Zhichao Chen, Yufeng Lv
Oncology Letters.2019;[Epub]     CrossRef
Tumor Response Assessment for Precision Cancer Therapy: Response Evaluation Criteria in Solid Tumors and Beyond
Mizuki Nishino
American Society of Clinical Oncology Educational Book.2018; (38): 1019.     CrossRef
Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe
Ralf Gutzmer, Kevin J. Harrington, Christoph Hoeller, Celeste Lebbé, Josep Malvehy, Katarina Öhrling, Gerald Downey, Reinhard Dummer
European Journal of Dermatology.2018; 28(6): 736.     CrossRef
Unidimensional measurement may be superior to assess primary tumor response after neoadjuvant chemotherapy for nasopharyngeal carcinoma
Chuanben Chen, Xiurong Lin, Yuanji Xu, Penggang Bai, Youping Xiao, Yuhui Pan, Chao Li, Zhizhong Lin, Mingwei Zhang, Yunbin Chen
Oncotarget.2017; 8(29): 46937.     CrossRef
Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
Toru Mizuguchi, Toshihiko Torigoe, Fukino Satomi, Hiroaki Shima, Goro Kutomi, Shigenori Ota, Masayuki Ishii, Hiroshi Hayashi, Sumiyo Asakura, Yoshihiko Hirohashi, Makoto Meguro, Yasutoshi Kimura, Toshihiko Nishidate, Kenji Okita, Masaho Ishino, Atsushi Mi
Surgery Today.2016; 46(2): 139.     CrossRef
Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors
Mustafa Aras, Tanju Y. Erdil, Faysal Dane, Serkan Gungor, Tunc Ones, Fuat Dede, Sabahat Inanir, Halil T. Turoglu
Nuclear Medicine Communications.2016; 37(1): 9.     CrossRef
Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review
Luca G. Campana, A. James P. Clover, Sara Valpione, Pietro Quaglino, Julie Gehl, Christian Kunte, Marko Snoj, Maja Cemazar, Carlo R. Rossi, Damijan Miklavcic, Gregor Sersa
Radiology and Oncology.2016; 50(1): 1.     CrossRef
Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review
Jung Han Kim
Oncotarget.2016; 7(12): 13680.     CrossRef
Assessment of Treatment Response Using PET
Sandip Basu, Rakesh Kumar, Rohit Ranade
PET Clinics.2015; 10(1): 9.     CrossRef
Single-Lesion Measurement per Organ for Assessing Tumor Response in Advanced Gastric Cancer
Hyeong Su Kim, Ji Won Kim, Jung Han Kim, Dae Ro Choi, A. Rum Han, Min-Joeng Kim, Byung Chun Kim, Dae Young Zang
Oncology.2015; 88(2): 69.     CrossRef
Tumor response assessment by measuring the single largest lesion per organ in patients with advanced non-small cell lung cancer
Hyeong Su Kim, Jung Han Kim, Ik Yang
Lung Cancer.2014; 85(3): 385.     CrossRef
Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies
Biomedical Reports.2014; 2(4): 452.     CrossRef
XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis
Fanghui Ye, Zhenfang Liu, Aihua Tan, Ming Liao, Zengnan Mo, Xiaobo Yang
Cancer Chemotherapy and Pharmacology.2013; 71(3): 733.     CrossRef
Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy
Matthew D. Galsky, Susan Krege, Chia‐Chi Lin, Noah Hahn, Thorsten Ecke, Erin Moshier, Guru Sonpavde, James Godbold, William K. Oh, Aristotle Bamias
Cancer.2013; 119(16): 3020.     CrossRef
Diagnostic and therapeutic imaging for cancer: Therapeutic considerations and future directions
Mack Roach, Jean‐Louis Alberini, Alain Paul Pecking, Alessandro Testori, Francesco Verrecchia, Javier Soteldo, Ute Ganswindt, John L. Joyal, John W. Babich, Russell S. Witte, Evan Unger, Ronald Gottlieb
Journal of Surgical Oncology.2011; 103(6): 587.     CrossRef